Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Tempest Therap. From $0.23 to $9.77 in 1 day

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Oct 12, 2023 1:42pm

87 Views

Post# 35680918

RE:RE:RE:RE:RE:RE:Tempest Therap. From $0.23 to $9.77 in 1 day

SP matters when management can't create shareholder value. Nobody knows about Oncy because of a deficient sales team. What, are we hoping for a 4000% day now, lol? Defecate in one hand, hope in the other...the posters here who are lashing out at my posts are doing so because they too are frustrated and losing confidence. So be it...good luck all.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages